News
Deion Sanders opened up about his bladder cancer diagnosis, raising awareness on symptoms, risk factors, and the importance ...
As July concludes, new treatments offer advances across kidney and bladder cancer, with breakthroughs in personalized vaccines and non-surgical therapies.
2d
Sportschosun on MSNDevelopment of Smartphone Bladder Cancer Early Diagnosis Kit...Close to 90% accuracyA research team led by Professor Seokho Kang of Urology (Professor Seokho Kang, Professor Shim Ji-sung, Professor Roh Tae-il, ...
Photocure ASA (OSE: PHO) today reported Hexvix®/Cysview® revenues of NOK 135.6 million in the second quarter of 2025 (Q2 2024: NOK ...
The FDA has granted Priority Review to TAR-200 for the treatment of patients with BCG-unresponsive high-risk non-muscle invasive bladder cancer with carcinoma in situ, with or without papillary tumors ...
4d
Sportschosun on MSNDetecting microhematuria more than twice in middle-aged people. We should suspect thisWhen you think of hematuria, you think of a state in which your urine is mixed with red blood. However, the presence of ...
The FDA has granted RMAT designation to detalimogene voraplasmid for the treatment of high-risk, BCG-unresponsive, NMIBC with CIS.
Normally, the sphincter remains closed as the bladder fills with urine. The weakened muscles and relaxed pelvic floor have trouble holding urine, so any movement that exerts a force on the abdominal ...
In a news conference this week discussing removal of his bladder due to cancer, University of Colorado football coach Deion ...
The Global Bladder Cancer Market was valued at USD 4.4 Billion in 2024, and it is expected to reach USD 7.2 Billion by 2035, ...
Johnson & Johnson has won U.S. Food and Drug Administration priority review for its application seeking approval of its TAR-200 drug delivery system in certain patients with high-risk, non-muscle ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results